Get started
Author

Martina Bottanelli

One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study
2024 · Camilla Muccini, Nicola Gianotti, et al. · Open Forum Infectious Diseases · 29
Safety, Tolerability, and Metabolic Effects of Long-Acting Cabotegravir and Rilpivirine in HIV Care: A Comprehensive Review
2025 · Martina Bottanelli, Antonella Castagna, et al. · Viruses · 19
PDF
A case of breakthrough mpox infection in an individual non-responder to MVA-BN vaccination
2023 · Martina Bottanelli, Emanuela Messina, et al. · The Lancet Infectious Diseases · 7
PDF
Increasing incidence and prevalence of metabolic syndrome in people living with HIV during the COVID-19 pandemic
2023 · Rebecka Papaioannu Borjesson, Laura Galli, et al. · Frontiers in Medicine · 7
PDF
Trend over time of HIV ‐1 drug resistance to nonnucleoside reverse transcriptase inhibitors ( NNRTIs ) and their drivers: A cohort study from Antiviral Response Cohort Analysis ( ARCA )
2023 · Ilaria Rancan, Chiara Cassol, et al. · HIV Medicine · 7
PDF
Emerging sexually transmitted infections outbreak: Dermatophytosis among men who have sex with men in Milan, Italy
2025 · Chiara Maci, Angelo Roberto Raccagni, et al. · International Journal of STD & AIDS · 5
Durability of lenacapavir in viremic heavily treatment-experienced people with HIV: real-world data from the PRESTIGIO Registry
2025 · Tommaso Clemente, Golnaz Torkjazi, et al. · Journal of Antimicrobial Chemotherapy · 4
Cardiometabolic complications in children and adolescents with HIV on antiretroviral therapy
2024 · Camilla Muccini, Martina Bottanelli, et al. · Expert Opinion on Drug Metabolism & Toxicology · 3
Is HDL-C Plasma Concentration a Possible Marker of HIV Replication? A Retrospective Cross-Sectional Analysis in Untreated HIV-Infected Individuals Accessing HIV Care in Italy. Data from The ICONA Foundation Study Cohort
2023 · Stefania Piconi, Martina Bottanelli, et al. · Archives of Microbiology & Immunology · 3
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19
2022 · Marco Ripa, Laura Galli, et al. · Open Forum Infectious Diseases · 3
PDF
Rezafungin as Primary Prophylaxis of Pneumocystis jirovecii Pneumonia in a Critically Ill Person Presenting with AIDS with Trimethoprim/Sulfamethoxazole Allergy: A Case Report
2026 · Martina Bottanelli, Alice Mulè, et al. · Journal of Fungi · 2
PDF
Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life setting
2024 · Rebecka Papaioannu Borjesson, Tommaso Clemente, et al. · Journal of Antimicrobial Chemotherapy · 2
Mortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration
2025 · Alisa Timiryasova, Lauren Greenberg, et al. · Cancers · 1
PDF
Thrice-weekly teicoplanin: an old drug for modern needs. Experience of its use as outpatient parenteral antibiotic therapy (OPAT) at infectious disease unit of Manzoni hospital (Lecco)
2025 · Valentina Morena, Federico Conti, et al. · Journal of Chemotherapy · 1
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry
2025 · D Armenia, G Marchegiani, et al. · Journal of Antimicrobial Chemotherapy · 1
PDF
Durability of multi-drug antiretroviral therapy (mega-ART) in treatment-experienced people with HIV in the ARCA database
2025 · Laura Labate, Barbara Rossetti, et al. · Antiviral Therapy · 1
Are glucagon‐like peptide 1 receptor agonists effective in decreasing body weight and body mass index in people living with diabetes and HIV ?
2023 · Martina Bottanelli, Laura Galli, et al. · HIV Medicine · 1
Disseminated Mycobacterium chimaera infection favoring the development of Kaposi’s sarcoma: a case report
2022 · Tommaso Clemente, Vincenzo Spagnuolo, et al. · Annals of Clinical Microbiology and Antimicrobials · 1
PDF
Challenging management of a post-coronavirus disease 2019 invasive Aspergillus sinusitis in a person living with HIV
2022 · Martina Bottanelli, Emanuela Messina, et al. · AIDS · 1
Virological outcomes, resistance profile and viral evolution of lenacapavir-based regimens in heavily treatment-experienced people: data from the PRESTIGIO Registry
2026 · Maria Mercedes Santoro, Daniele Spalletta, et al. · Journal of Antimicrobial Chemotherapy
PDF
Acute hepatitis B following a switch to long-acting cabotegravir plus rilpivirine in an individual with a history of hepatitis B vaccination
2025 · Valentina Morena, Nicole Gemignani, et al. · Sexually Transmitted Infections
PRESTIGIO RING: "Persistent low-level viremia with preserved immunological profile in people with multidrug-resistant HIV: is it time to defer switching?"
2025 · Tommaso Clemente, Martina Bottanelli, et al. · PubMed
P51 Drug resistance mutations among ART-naïve individuals in lecco
2025 · F Conti, N Gemignani, et al. · Sexually Transmitted Infections
TD-11 Viral blips among people living with HIV following recommended vaccines
2024 · B Trentacapilli, AR Raccagni, et al. · Sexually Transmitted Infections
PDF
Risk of Cardiovascular Diseases or Mortality in People With Higher Values of HIV-1 DNA
2023 · Martina Bottanelli, Daniele Ceccarelli, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes
Works count: 28
Citation count: 98
H-index: 5
I10-index: 2
Year
Topic
Type